Document is current
Any future updates will be listed below
-
Authors
Shin, Joonyoung
Jeong, Tae Seong
Jung, Ho Seok
Kim, Dongwoung
Kim, Cheol-Hyun
Yi, SangHak
Kang, Hyung Won
Han, Dongwoon
Kim, Sungchul https://orcid.org/0009-0002-9513-0758
-
Funding
Funding for this research was provided by:
Korea Health Technology R&D Project (HI21C2525)
- License Information
-
More Information
Article History
Received: 23 February 2025
Accepted: 12 February 2026
First Online: 26 February 2026
Declarations
:
: The trial protocol has been approved by the IRB of Wonkwang University Hospital Gwangju Korean Medical Center and Wonkwang University Hospital (WKIRB 2021/14–19 and WKUH IRB 2023–10-005–012, respectively). The study is registered with the national clinical trial registry, the Clinical Research Information Service (CRIS), which is a primary registry of the World Health Organization International Clinical Trials Registry Platform (KCT0008433). Investigational New Drug (IND) status (30731) was granted by the Ministry of Food and Drug Safety (MFDS). Any protocol modifications will be submitted for approval by the IRBs and the MFDS before implementation. Written informed consent was obtained from all participants prior to their involvement in the study.
: Not applicable.This manuscript does not contain individual personal data from patients.
: The authors declare that they have no competing interests.
